These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14626043)

  • 1. Anaemia: causes and treatment.
    Campbell K
    Nurs Times; 2003 Oct 28-Nov 3; 99(43):30-3. PubMed ID: 14626043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating anemia with erythropoiesis-stimulating agents: effects on quality of life.
    Moossavi S; Freedman BI
    Arch Intern Med; 2009 Jun; 169(12):1100-1. PubMed ID: 19546408
    [No Abstract]   [Full Text] [Related]  

  • 3. [The general practitioner and anemia].
    Sztern B
    Rev Med Brux; 1998 Sep; 19(4):A239-40. PubMed ID: 9805950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory diagnosis and investigation of anaemia.
    Campbell K
    Nurs Times; 2005 May 31-Jun 6; 101(22):36-9. PubMed ID: 15960107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of anaemia.
    Campbell K
    Nurs Times; 2004 Nov 23-29; 100(47):40-3. PubMed ID: 15626047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anemia in the elderly: how should we define it, when does it matter, and what can be done?
    Steensma DP; Tefferi A
    Mayo Clin Proc; 2007 Aug; 82(8):958-66. PubMed ID: 17673065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of epoetin in the management of anaemia in patients with lung cancer.
    Morère JF
    Lung Cancer; 2004 Nov; 46(2):149-56. PubMed ID: 15474662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimising the management of anaemia in patients with cancer with practice guidelines using erythropoiesis-stimulating proteins.
    Smyth D; Zumbrink S
    Eur J Oncol Nurs; 2005; 9 Suppl 1():S3-S13. PubMed ID: 16202653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents.
    Aapro MS; Link H
    Oncologist; 2008; 13 Suppl 3():33-6. PubMed ID: 18458123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current trends in the management of anaemia in solid tumours and haematological malignancies.
    van Eeden R; Rapoport BL
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):189-94. PubMed ID: 27054286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment.
    Repetto L; Moeremans K; Annemans L;
    Cancer Treat Rev; 2006; 32 Suppl 2():S5-9. PubMed ID: 16725267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How do we optimally evaluate iron stores in dialyzed patients treated with erythropoiesis stimulating agent?].
    Kessler M; Salignac S; Aimone-Gastin I
    Nephrol Ther; 2006 Sep; 2 Suppl 4():S261-5. PubMed ID: 17373268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoiesis-stimulating agents in patients with cancer: update on safety issues.
    Pirker R
    Expert Opin Drug Saf; 2009 Sep; 8(5):515-22. PubMed ID: 19637988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study.
    Ludwig H; Aapro M; Bokemeyer C; Macdonald K; Soubeyran P; Turner M; Albrecht T; Abraham I
    Eur J Cancer; 2009 Jun; 45(9):1603-15. PubMed ID: 19278851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anaemia treatment in gynaecology: use of epoetin in onco-gynaecology and gynaecological surgery].
    Kirchner V;
    Rev Med Suisse; 2005 Apr; 1(15):1041-3, 1046-7. PubMed ID: 15918284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comorbidity, anemia and response to erythropoiesis stimulating agents in chronic hemodialysis].
    Anaya S; Rivera F; Sánchez de la Nieta MD; Carreño A; Vozmediano C; Alcaide MP; Arambarri M; Nieto J; Caparrós G; Ferreras I
    Nefrologia; 2008; 28(2):186-92. PubMed ID: 18454709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triumph and tragedy: anemia management in chronic kidney disease.
    Novak JE; Szczech LA
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):580-8. PubMed ID: 18941350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of erythropoiesis in protein energy malnutrition.
    el-Nawawy A; Barakat S; Elwalily T; Abdel-Moneim Deghady A; Hussein M
    East Mediterr Health J; 2002; 8(2-3):281-9. PubMed ID: 15339115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for anemia, taking risks into consideration: erythropoiesis-stimulating agents versus transfusions.
    Spano JP; Khayat D
    Oncologist; 2008; 13 Suppl 3():27-32. PubMed ID: 18458122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ORAMA: a study to investigate EBPG impact on renal anaemia - design and baseline data.
    Locatelli F; Covic A; Macdougall IC; Wiecek A;
    J Nephrol; 2008; 21(4):592-603. PubMed ID: 18651551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.